Asylum Research is the technology leader for atomic force microscopy (AFM) for materials and biosciences. Featured is Cypher™ AFM, the world's fastest and highest resolution AFM with closed loop atomic resolution for the most accurate images and measurements possible, >20X faster imaging, and many ease of use features included Spot-On(tm) automated laser alignment; the MFP-3D™ AFM family allows, precision and accuracy for larger samples with advanced imaging capabilities and environmental accessories, and compatibility with inverted optical microscopes for combined AFM/Optical measurements.
For more information, please visit www.asylumresearch.com
The NanoInk’s NanoFabrication Systems Division provides direct write, tip-based desktop lithography instruments and services for micro and nanoscale patterning. The product portfolio optimizes the controllable deposition of many different materials from nanoscale tips, all under ambient conditions, to rapidly generate user defined multiplexed patterns with feature sizes as small as 50 nm or as large as 10 microns. The ability to design and create custom engineered and functionalized surfaces with nanometer scale precision and sub-cellular resolution enables cutting edge nanofabrication, nanoengineering and nanobiological applications.
For more information, please visit www.nanoink.net
Ocean Nano Tech was founded in 2004 in Fayetteville, AR. Now located in its own facility in Springdale Arkansas, it has four labs which are fully equipped to conduct synthetic organic chemistry, nanoparticle synthesis/characterization, bioconjugation, cell culture, cell/molecular biological assays, and in vitro diagnostics research and development.
Ocean’s mission is to develop novel techniques for the production and processing of fluorescent and magnetic nanocrystals for electronic and biomedical applications. Ocean’s core competences are 1) the synthesis of high quality quantum dots and magnetic nanoparticles; 2) the conversion of quantum dots and magnetic nanoparticles to water soluble and biocompatible nanoparticles; 3) development of stable conjugation chemistry of the nanoparticles for biomedical application.
For more information, please see oceannanotech.com
Companies interested in sponsoring the conference should contact:
Tom Faulkner
Email: t.faulkner@elsevier.com
Tel: +31 (0) 20 485 2175
Fax: +31 (0) 20 485 2623
